Morgan Stanley’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $45.2M | Buy |
|
|||||
|
2023
Q3 | $7.57M | Sell |
|
|||||
|
2023
Q2 | $9.02M | Sell |
|
|||||
|
2023
Q1 | $8.65M | Buy |
|
|||||
|
2022
Q4 | $1.71M | Buy |
|
|||||
|
2022
Q3 | $763K | Sell |
|
|||||
|
2022
Q2 | $1.37M | Buy |
|
|||||
|
2022
Q1 | $388K | Buy |
|
|||||
|
2021
Q4 | $374K | Sell |
|
|||||
|
2021
Q3 | $656K | Sell |
|
|||||
|
2021
Q2 | $2.21M | Buy |
|
|||||
|
2021
Q1 | $527K | Buy |
|
|||||
|
2020
Q4 | $435K | Buy |
|
|||||
|
2020
Q3 | $456K | Sell |
|
|||||
|
2020
Q2 | $981K | Buy |
|
|||||
|
2020
Q1 | $232K | Sell |
|
|||||
|
2019
Q4 | $4.76M | Buy |
|
|||||
|
2019
Q3 | $2.17M | Buy |
|
|||||
|
2019
Q2 | $45K | Sell |
|
|||||
|
2019
Q1 | $432K | Sell |
|
|||||
|
2018
Q4 | $2.44M | Buy |
|
|||||
|
2018
Q3 | $1.31M | Sell |
|
|||||
|
2018
Q2 | $2.03M | Buy |
|
|||||
|
2018
Q1 | $579K | Sell |
|
|||||
|
2017
Q4 | $499K | Sell |
|
|||||
|
2017
Q3 | $460K | Buy |
|
|||||
|
2017
Q2 | $121K | Buy |
|
|||||
|
2017
Q1 | $71K | Buy |
|
|||||
|
2016
Q4 | $4K | Buy |
|
|||||
|
2016
Q3 | $3K | Buy |
|
|||||
|
2016
Q2 | $1K | Buy |
|
|||||
|
2016
Q1 | $0 | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $5K | Hold |
|
|||||
|
2015
Q2 | $7K | Sell |
|
|||||
|
2015
Q1 | $610K | Buy |
|
|||||
|
2014
Q4 | $189K | Buy |
|
|||||
|
2014
Q3 | $0 | Buy |
|